{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:04:29Z","timestamp":1759341869345},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T00:00:00Z","timestamp":1368835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00223-013-9735-5","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T07:11:05Z","timestamp":1368774665000},"page":"78-85","source":"Crossref","is-referenced-by-count":5,"title":["Ubiquitin-Like Domain of IKK\u03b2 Regulates Osteoclastogenesis and Osteolysis"],"prefix":"10.1007","volume":"93","author":[{"given":"Yanhong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse E.","family":"Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Abu-Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,18]]},"reference":[{"key":"9735_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1568008054863808","volume":"5","author":"Y Abu-Amer","year":"2005","unstructured":"Abu-Amer Y (2005) Advances in osteoclast differentiation and function. Curr Drug Targets Immune Endocr Metabol Disord 5:347\u2013355","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"9735_CR2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum SL (2007) Osteoclasts: what do they do and how do they do it? Am J Pathol 170:427\u2013435","journal-title":"Am J Pathol"},{"key":"9735_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar1857","volume":"8","author":"SL Teitelbaum","year":"2006","unstructured":"Teitelbaum SL (2006) Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther 8:201","journal-title":"Arthritis Res Ther"},{"key":"9735_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.coph.2009.06.007","volume":"9","author":"Y Abu-Amer","year":"2009","unstructured":"Abu-Amer Y (2009) Inflammation, cancer, and bone loss. Curr Opin Pharmacol 9:427\u2013433","journal-title":"Curr Opin Pharmacol"},{"key":"9735_CR5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1197-1189","volume":"3","author":"Y Abu-Amer","year":"1997","unstructured":"Abu-Amer Y, Tondravi MM (1997) NF\u03baB and bone: the breaking point. Nat Med 3:1189\u20131190","journal-title":"Nat Med"},{"key":"9735_CR6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749\u2013759","journal-title":"Nat Rev Immunol"},{"key":"9735_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","volume":"3","author":"M Karin","year":"2004","unstructured":"Karin M, Yamamoto Y, Wang M (2004) The IKK NF-kB system: a treasure trove for drug development. Nat Rev 3:17\u201326","journal-title":"Nat Rev"},{"key":"9735_CR8","author":"H H\u00e8acker","year":"2006","unstructured":"H\u00e8acker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE. doi: 10.1126\/stke.3572006re13","journal-title":"Sci STKE"},{"key":"9735_CR9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-6632.2009.05315.x","volume":"1192","author":"BF Boyce","year":"2010","unstructured":"Boyce BF, Yao Z, Xing L (2010) Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192:367\u2013375","journal-title":"Ann N Y Acad Sci"},{"key":"9735_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(99)00105-2","volume":"25","author":"B Boyce","year":"1999","unstructured":"Boyce B, Xing L, Fransozo G, Siebenlist U (1999) Required and nonessential functions of nuclear factor-kB in bone cells. Bone 25:137\u2013139","journal-title":"Bone"},{"key":"9735_CR11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/08916930701694543","volume":"41","author":"Y Abu-Amer","year":"2008","unstructured":"Abu-Amer Y, Darwech I, Otero J (2008) Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss. Autoimmunity 41:204\u2013211","journal-title":"Autoimmunity"},{"key":"9735_CR12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jor.20184","volume":"24","author":"JC Clohisy","year":"2006","unstructured":"Clohisy JC, Yamanaka Y, Faccio R, Abu-Amer Y (2006) Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis. J Orthopaed Res 24:1358\u20131365","journal-title":"J Orthopaed Res"},{"key":"9735_CR13","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.C400258200","volume":"279","author":"S Dai","year":"2004","unstructured":"Dai S, Hirayama T, Abbas S, Abu-Amer Y (2004) The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279:37219\u201337222","journal-title":"J Biol Chem"},{"key":"9735_CR14","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1074\/jbc.M207700200","volume":"278","author":"KK Rehman","year":"2003","unstructured":"Rehman KK, Bertera S, Bottino R, Balamurugan AN, Mai JC, Mi Z, Trucco M, Robbins PD (2003) Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J Biol Chem 278:9862\u20139868","journal-title":"J Biol Chem"},{"key":"9735_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00774-008-0026-6","volume":"27","author":"NS Soysa","year":"2009","unstructured":"Soysa NS, Alles N, Shimokawa H, Jimi E, Aoki K, Ohya K (2009) Inhibition of the classical NF-kappa B pathway prevents osteoclast bone-resorbing activity. J Bone Miner Metab 27:131\u2013139","journal-title":"J Bone Miner Metab"},{"key":"9735_CR16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcb.22364","volume":"108","author":"I Darwech","year":"2009","unstructured":"Darwech I, Otero J, Alhawagri M, Dai S, Abu-Amer Y (2009) Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis. J Cell Biochem 108:1337\u20131345","journal-title":"J Cell Biochem"},{"key":"9735_CR17","doi-asserted-by":"crossref","first-page":"e38694","DOI":"10.1371\/journal.pone.0038694","volume":"7","author":"JE Otero","year":"2012","unstructured":"Otero JE, Chen T, Zhang K, Abu-Amer Y (2012) Constitutively active canonical +NF-kappaB pathway induces severe bone loss in mice. PLoS One 7:e38694","journal-title":"PLoS One"},{"key":"9735_CR18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4","volume":"25","author":"JE Otero","year":"2010","unstructured":"Otero JE, Dai S, Alhawagri MA, Darwech I, Abu-Amer Y (2010) IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis. J Bone Miner Res 25:1282\u20131294","journal-title":"J Bone Miner Res"},{"key":"9735_CR19","doi-asserted-by":"crossref","first-page":"25522","DOI":"10.1074\/jbc.M110.121533","volume":"285","author":"I Darwech","year":"2010","unstructured":"Darwech I, Otero JE, Alhawagri MA, Abu-Amer Y (2010) Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis. J Biol Chem 285:25522\u201325530","journal-title":"J Biol Chem"},{"key":"9735_CR20","doi-asserted-by":"crossref","first-page":"24546","DOI":"10.1074\/jbc.M800434200","volume":"283","author":"JE Otero","year":"2008","unstructured":"Otero JE, Dai S, Foglia D, Alhawagri M, Vacher J, Pasparakis M, Abu-Amer Y (2008) Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem 283:24546\u201324553","journal-title":"J Biol Chem"},{"key":"9735_CR21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063\u20131066","journal-title":"Gene Ther"},{"key":"9735_CR22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.gt.3301197","volume":"7","author":"RD Anderson","year":"2000","unstructured":"Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL (2000) A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7:1034\u20131038","journal-title":"Gene Ther"},{"key":"9735_CR23","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4049\/jimmunol.147.5.1694","volume":"147","author":"C Drouet","year":"1991","unstructured":"Drouet C, Shakhov AN, Jongeneel CV (1991) Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol 147:1694\u20131700","journal-title":"J Immunol"},{"key":"9735_CR24","doi-asserted-by":"crossref","first-page":"45528","DOI":"10.1074\/jbc.M408579200","volume":"279","author":"MJ May","year":"2004","unstructured":"May MJ, Larsen SE, Shim JH, Madge LA, Ghosh S (2004) A novel ubiquitin-like domain in Ikappa B-kinase beta is required for functional activity of the kinase. J Biol Chem 279:45528\u201345539","journal-title":"J Biol Chem"},{"key":"9735_CR25","doi-asserted-by":"crossref","first-page":"45992","DOI":"10.1074\/jbc.M206494200","volume":"277","author":"MJ May","year":"2002","unstructured":"May MJ, Marienfeld RB, Ghosh S (2002) Characterization of the Ikappa B-kinase NEMO binding domain. J Biol Chem 277:45992\u201346000","journal-title":"J Biol Chem"},{"issue":"Suppl 4","key":"9735_CR26","doi-asserted-by":"crossref","first-page":"iv81","DOI":"10.1136\/ard.2005.042721","volume":"64","author":"MG Ruocco","year":"2005","unstructured":"Ruocco MG, Karin M (2005) IKK{beta} as a target for treatment of inflammation induced bone loss. Ann Rheum Dis 64(Suppl 4):iv81\u2013iv85","journal-title":"Ann Rheum Dis"},{"key":"9735_CR27","doi-asserted-by":"crossref","first-page":"20077","DOI":"10.1074\/jbc.M208619200","volume":"278","author":"S Abbas","year":"2003","unstructured":"Abbas S, Abu-Amer Y (2003) Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha. J Biol Chem 278:20077\u201320082","journal-title":"J Biol Chem"},{"key":"9735_CR28","doi-asserted-by":"crossref","first-page":"30499","DOI":"10.1074\/jbc.M104725200","volume":"276","author":"Y Abu-Amer","year":"2001","unstructured":"Abu-Amer Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL (2001) TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J Biol Chem 276:30499\u201330503","journal-title":"J Biol Chem"},{"key":"9735_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-0266(03)00156-6","volume":"22","author":"J Clohisy","year":"2004","unstructured":"Clohisy J, Hirayama T, Frazier E, Han S, Abu-Amer Y (2004) NF-kB signaing blockade abolishes implant particle-induced osteoclastogenesis. J Orthop Res 22:13\u201320","journal-title":"J Orthop Res"},{"key":"9735_CR30","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.4049\/jimmunol.171.10.5547","volume":"171","author":"JC Clohisy","year":"2003","unstructured":"Clohisy JC, Roy BC, Biondo C, Frazier E, Willis D, Teitelbaum SL, Abu-Amer Y (2003) Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis. J Immunol 171:5547\u20135553","journal-title":"J Immunol"},{"key":"9735_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-0-387-72009-8_16","volume":"602","author":"MG Ruocco","year":"2007","unstructured":"Ruocco MG, Karin M (2007) Control of osteoclast activity and bone loss by IKK subunits: new targets for therapy. Adv Exp Med Biol 602:125\u2013134","journal-title":"Adv Exp Med Biol"},{"key":"9735_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S (2011) NF-kappaB, inflammation, and metabolic disease. Cell Metab 13:11\u201322","journal-title":"Cell Metab"},{"key":"9735_CR33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.0105-2896.2005.00329.x","volume":"208","author":"E Jimi","year":"2005","unstructured":"Jimi E, Ghosh S (2005) Role of nuclear factor-kappaB in the immune system and bone. Immunol Rev 208:80\u201387","journal-title":"Immunol Rev"},{"key":"9735_CR34","doi-asserted-by":"crossref","first-page":"43272","DOI":"10.1074\/jbc.M508656200","volume":"280","author":"RS Carter","year":"2005","unstructured":"Carter RS, Pennington KN, Arrate P, Oltz EM, Ballard DW (2005) Site-specific Monoubiquitination of I{kappa}B kinase IKKbeta regulates its phosphorylation and persistent activation. J Biol Chem 280:43272\u201343279","journal-title":"J Biol Chem"},{"key":"9735_CR35","doi-asserted-by":"crossref","first-page":"48903","DOI":"10.1074\/jbc.M310686200","volume":"278","author":"RS Carter","year":"2003","unstructured":"Carter RS, Pennington KN, Ungurait BJ, Arrate P, Ballard DW (2003) Signal-induced ubiquitination of I{kappa}B kinase-{beta}. J Biol Chem 278:48903\u201348906","journal-title":"J Biol Chem"},{"key":"9735_CR36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jor.21555","volume":"30","author":"M Alhawagri","year":"2012","unstructured":"Alhawagri M, Yamanaka Y, Ballard D, Oltz E, Abu-Amer Y (2012) Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis. J Orthop Res 30:554\u2013560","journal-title":"J Orthop Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-013-9735-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9735-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T20:15:13Z","timestamp":1688242513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-013-9735-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["9735"],"URL":"https:\/\/doi.org\/10.1007\/s00223-013-9735-5","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,18]]}}}